Nuvectra to Report First Quarter 2017 Financial Results on May 9, 2017
27 avr. 2017 08h30 HE
|
Nuvectra
PLANO, Texas, April 27, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the...
Nuvectra Announces Cowen & Company Hosted Physician Panel on Spinal Cord Stimulation on March 29, 2017
27 mars 2017 08h30 HE
|
Nuvectra
PLANO, Texas, March 27, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Cowen and Company and The Ruth Group are hosting...
Nuvectra™ Reports Fourth Quarter and Full Year 2016 Financial Results
07 mars 2017 08h01 HE
|
Nuvectra
PLANO, Texas, March 07, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the fourth quarter and full year...
Nuvectra to Present at the 29th Annual ROTH Conference
06 mars 2017 08h01 HE
|
Nuvectra
PLANO, Texas, March 06, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter...
Nuvectra to Present at the Cowen and Company 37th Annual Health Care Conference
01 mars 2017 08h01 HE
|
Nuvectra
PLANO, Texas, March 01, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and...
Nuvectra to Report Fourth Quarter 2016 Financial Results on March 7, 2017
21 févr. 2017 08h01 HE
|
Nuvectra
PLANO, Texas, Feb. 21, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the...
Nuvectra Extends Timeline of Existing Credit Facility
14 févr. 2017 16h01 HE
|
Nuvectra
PLANO, Texas, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it has reached an agreement with the lenders of...
Nuvectra to Present at the Leerink Partners 6th Annual Global Healthcare Conference
06 févr. 2017 08h00 HE
|
Nuvectra
PLANO, Texas, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter...
Nuvectra Files Regulatory Submissions for FDA and CE Mark Approvals of the Virtis™ Sacral Nerve Stimulation (SNS) System
01 févr. 2017 10h00 HE
|
Nuvectra
PLANO, Texas, Feb. 01, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it has filed regulatory submissions with the U.S....
Nuvectra Receives Frost & Sullivan’s New Product Innovation Award for Its Algovita® SCS System
17 janv. 2017 09h31 HE
|
Nuvectra
PLANO, Texas, Jan. 17, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, has recently been named recipient of the Frost & Sullivan North...